662. Recurrence of Infection and Emergence of Drug Resistance After Treatment with Meropenem/Vaborbactam Compared with Ceftazidime/Avibactam in Carbapenem-Resistant Enterobacteriaceae Infections

BACKGROUND: Options for treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections were historically limited to antibiotics with limited efficacy and significant toxicities. Ceftazidime/avibactam (CA) and meropenem/vaborbactam (MV) are superior to older regimens; however, a direct compari...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackley, Renee, Roshdy, Danya, Isip, Jacqueline, Minor, Sarah B, Elchynski, Amanda L, Anderson, William E, Capraro, Gerald A, Polk, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811309/
http://dx.doi.org/10.1093/ofid/ofz360.730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811309/
http://dx.doi.org/10.1093/ofid/ofz360.730

Ejemplares similares